Local laboratory‐run donor‐derived cell‐free DNA assay for rejection surveillance in heart transplantation—first six months of clinical experience
Open Access
- 25 July 2023
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 37 (9) , e15078
Abstract
Donor-derived cell-free DNA (dd-cfDNA) is a blood biomarker detecting graft injury with high negative predictive value. While non-invasive strategies for heart transplant (HTx) rejection surveillance are widely adopted in the United States with centralized testing, data on the feasibility of dd-cfDNA assay at the local level are lacking. Here, we report the first 6 months of experience with a local laboratory-run dd-cfDNA assay in the routine clinical surveillance setting. Twenty-six HTx patients with stable graft function were transitioned from endomyocardial biopsy-based (EMB) to dd-cfDNA-led rejection surveillance using a commercially available next-generation sequencing-based assay. In the 90 samples analyzed, dd-cfDNA fraction remained continuously low in most patients, thus 88% of surveillance EMBs could be safely avoided. In the case of ≥.25% dd-cfDNA, EMB was performed. There was no missed rejection. Our data show the feasibility to analyze dd-cfDNA at the local level and successful implementation of this non-invasive surveillance method into clinical practice, thus considerably reducing the frequency of invasive surveillance EMBs.Keywords
This publication has 9 references indexed in Scilit:
- The End of Endomyocardial Biopsy?JACC: Heart Failure, 2023
- The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2022
- A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantationThe Journal of Heart and Lung Transplantation, 2022
- Clinical utility of donor-derived cell-free DNA testing in cardiac transplantationThe Journal of Heart and Lung Transplantation, 2021
- Cell-Free DNA to Detect Heart Allograft Acute RejectionCirculation, 2021
- Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter studyAmerican Journal of Transplantation, 2019
- Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant RecipientsThe Journal of Molecular Diagnostics, 2016
- The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantationThe Journal of Heart and Lung Transplantation, 2013
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005